Hypertension Scientific Sessions 2020 is supported by independent medical education grants from Medtronic and Chiesi USA, Inc.

Hypertension Update 2021

Originally published 8 Dec 2020 | Hypertension

Getty Images 1281657485

As Hypertension begins its 42nd year, the current editorial team, led by Editor-in-Chief Prof Anna F. Dominiczak and Deputy Editor Prof Rhian M. Touyz, begin their last year at the helm of this prestigious journal. As we reflect on what has been a challenging and unprecedented year, the Editors wish to thank our many readers for their time spent reviewing manuscripts, submitting the best research to Hypertension, and providing feedback so that Hypertension remains the premier journal devoted to hypertension research. This is evidenced by the results of the Journal Citation Reports scientific impact factor of Hypertension for 2019 of 7.713, the highest of any journal devoted to basic, population, and clinical hypertension research. The Journal Citation Reports also reports a 2019 5-year impact factor of 7.206. The commitment and energy of our Editorial Board Members, readers, reviewers, and authors are appreciated. On behalf of the entire editorial team, it is with pleasure that we share with you a few key highlights from the past 12 months.

The full text of this article can be found at : https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.16668